Pharmacy Benefit Managers – 2025 Litigation and Policy Landscape: BI Replay

On Demand

Duration: 48 Minutes

Original Date: February 04, 2025

First name

Last name

Email address

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BIoomberg Intelligence analysts Justin Teresi and Duane Wright provide an overview of the litigation and policy hurdles facing pharmacy benefit managers (PBMs) heading into 2025. Legal issues to be covered include the Federal Trade Commission’s existing lawsuit against UnitedHealth’s Optum, CVS’ Caremark and Cigna’s Express Scripts over pricing policies and drug rebate programs regarding insulin, as well as a likely ongoing investigation by the Department of Justice. Congress and the Trump administration are expected to maintain policy pressure on the industry. Legislative and regulatory changes to PBM business practices are possible as lawmakers pursue efforts to lower drug prices

Pharmacy Benefit Managers – 2025 Litigation and Policy Landscape: BI Replay

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.